Cargando…
Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study
AIM: To determine in vitro susceptibility of multiresistant bacterial isolates to fosfomycin. METHODS: In this prospective in vitro study (local non-random sample, level of evidence 3), 288 consecutively collected multiresistant bacterial isolates from seven medical centers in Croatia were tested fr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941293/ https://www.ncbi.nlm.nih.gov/pubmed/29740989 http://dx.doi.org/10.3325/cmj.2018.59.56 |
_version_ | 1783321260305940480 |
---|---|
author | Bielen, Luka Likić, Robert Erdeljić, Viktorija Mareković, Ivana Firis, Nataša Grgić-Medić, Marijana Godan, Ana Tomić, Ivan Hunjak, Blaženka Markotić, Alemka Bejuk, Danijela Tičić, Vladimira Balzar, Silvana Bedenić, Branka |
author_facet | Bielen, Luka Likić, Robert Erdeljić, Viktorija Mareković, Ivana Firis, Nataša Grgić-Medić, Marijana Godan, Ana Tomić, Ivan Hunjak, Blaženka Markotić, Alemka Bejuk, Danijela Tičić, Vladimira Balzar, Silvana Bedenić, Branka |
author_sort | Bielen, Luka |
collection | PubMed |
description | AIM: To determine in vitro susceptibility of multiresistant bacterial isolates to fosfomycin. METHODS: In this prospective in vitro study (local non-random sample, level of evidence 3), 288 consecutively collected multiresistant bacterial isolates from seven medical centers in Croatia were tested from February 2014 until October 2016 for susceptibility to fosfomycin and other antibiotics according to Clinical and Laboratory Standards Institute methodology. Susceptibility to fosfomycin was determined by agar dilution method, while disc diffusion were performed for in vitro testing of other antibiotics. Polymerase chain reaction and sequencing was performed for the majority of extended spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae (K. pneumoniae) and carbapenem-resistant isolates. RESULTS: The majority of 288 multiresistant bacterial isolates (82.6%) were susceptible to fosfomycin. The 236 multiresistant Gram-negative isolates showed excellent susceptibility to fosfomycin. Susceptibility rates were as follows: Escherichia coli ESBL 97%, K. pneumoniae ESBL 80%, Enterobacter species 85.7%, Citrobacter freundii 100%, Proteus mirabilis 93%, and Pseudomonas aeruginosa 60%. Of the 52 multiresistant Gram-positive isolates, methicillin-resistant Staphylococcus aureus showed excellent susceptibility to fosfomycin (94.4%) and vancomycin-resistant enterococcus showed low susceptibility to fosfomycin (31%). Polymerase chain reaction analysis of 36/50 ESBL-producing K. pneumoniae isolates showed that majority of isolates had CTX-M-15 beta lactamase (27/36) preceded by ISEcp insertion sequence. All carbapenem-resistant Enterobacter and Citrobacter isolates had bla(VIM-1) metallo-beta-lactamase gene. CONCLUSION: With the best in vitro activity among the tested antibiotics, fosfomycin could be an effective treatment option for infections caused by multiresistant Gram-negative and Gram-positive bacterial strains in the hospital setting. |
format | Online Article Text |
id | pubmed-5941293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Croatian Medical Schools |
record_format | MEDLINE/PubMed |
spelling | pubmed-59412932018-05-11 Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study Bielen, Luka Likić, Robert Erdeljić, Viktorija Mareković, Ivana Firis, Nataša Grgić-Medić, Marijana Godan, Ana Tomić, Ivan Hunjak, Blaženka Markotić, Alemka Bejuk, Danijela Tičić, Vladimira Balzar, Silvana Bedenić, Branka Croat Med J Basic Science AIM: To determine in vitro susceptibility of multiresistant bacterial isolates to fosfomycin. METHODS: In this prospective in vitro study (local non-random sample, level of evidence 3), 288 consecutively collected multiresistant bacterial isolates from seven medical centers in Croatia were tested from February 2014 until October 2016 for susceptibility to fosfomycin and other antibiotics according to Clinical and Laboratory Standards Institute methodology. Susceptibility to fosfomycin was determined by agar dilution method, while disc diffusion were performed for in vitro testing of other antibiotics. Polymerase chain reaction and sequencing was performed for the majority of extended spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae (K. pneumoniae) and carbapenem-resistant isolates. RESULTS: The majority of 288 multiresistant bacterial isolates (82.6%) were susceptible to fosfomycin. The 236 multiresistant Gram-negative isolates showed excellent susceptibility to fosfomycin. Susceptibility rates were as follows: Escherichia coli ESBL 97%, K. pneumoniae ESBL 80%, Enterobacter species 85.7%, Citrobacter freundii 100%, Proteus mirabilis 93%, and Pseudomonas aeruginosa 60%. Of the 52 multiresistant Gram-positive isolates, methicillin-resistant Staphylococcus aureus showed excellent susceptibility to fosfomycin (94.4%) and vancomycin-resistant enterococcus showed low susceptibility to fosfomycin (31%). Polymerase chain reaction analysis of 36/50 ESBL-producing K. pneumoniae isolates showed that majority of isolates had CTX-M-15 beta lactamase (27/36) preceded by ISEcp insertion sequence. All carbapenem-resistant Enterobacter and Citrobacter isolates had bla(VIM-1) metallo-beta-lactamase gene. CONCLUSION: With the best in vitro activity among the tested antibiotics, fosfomycin could be an effective treatment option for infections caused by multiresistant Gram-negative and Gram-positive bacterial strains in the hospital setting. Croatian Medical Schools 2018-04 /pmc/articles/PMC5941293/ /pubmed/29740989 http://dx.doi.org/10.3325/cmj.2018.59.56 Text en Copyright © 2018 by the Croatian Medical Journal. All rights reserved. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Basic Science Bielen, Luka Likić, Robert Erdeljić, Viktorija Mareković, Ivana Firis, Nataša Grgić-Medić, Marijana Godan, Ana Tomić, Ivan Hunjak, Blaženka Markotić, Alemka Bejuk, Danijela Tičić, Vladimira Balzar, Silvana Bedenić, Branka Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title_full | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title_fullStr | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title_full_unstemmed | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title_short | Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study |
title_sort | activity of fosfomycin against nosocomial multiresistant bacterial pathogens from croatia: a multicentric study |
topic | Basic Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941293/ https://www.ncbi.nlm.nih.gov/pubmed/29740989 http://dx.doi.org/10.3325/cmj.2018.59.56 |
work_keys_str_mv | AT bielenluka activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT likicrobert activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT erdeljicviktorija activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT marekovicivana activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT firisnatasa activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT grgicmedicmarijana activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT godanana activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT tomicivan activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT hunjakblazenka activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT markoticalemka activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT bejukdanijela activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT ticicvladimira activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT balzarsilvana activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy AT bedenicbranka activityoffosfomycinagainstnosocomialmultiresistantbacterialpathogensfromcroatiaamulticentricstudy |